机构

• 上海药物研究所 [23]
• 合肥物质科学研究院 [13]
• 长春应用化学研究所 [8]
• 上海应用物理研究所 [5]
• 自动化研究所 [4]
• 宁波材料技术与工程研... [3]
• 更多

采集方式

• OAI收割 [76]
• iSwitch采集 [2]

内容类型

• 期刊论文 [78]

发表日期

• 2025 [1]
• 2024 [6]
• 2023 [2]
• 2022 [11]
• 2021 [7]
• 2020 [4]
• 更多

学科主题

• Chemistry [2]
• Cell Biolo... [1]
• Chemistry,... [1]
• Chemistry;... [1]
• Materials ... [1]
• Oncology [1]
• 更多

筛选

浏览/检索结果: 共78条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Stimuli-Responsive Nano Drug Delivery Systems for the Treatment of Neurological Diseases 期刊论文  OAI收割 SMALL, 2025, 页码: 21 作者:  Dai, Xi-jian;  Li, Wen-Jia;  Xie, Dong-Dong;  Liu, Bi-xia;  Gong, Lianggeng   |  收藏  |  浏览/下载：9/0  |  提交时间：2025/04/01 drug release  nanomaterial  neurological diseases  stimulus-responsive nanodrug delivery system  targeted therapy   Shape Engineering of Exosomes for Endoplasmic Reticulum-Targeted Delivery and Amplified Anticancer Efficacy 期刊论文  OAI收割 NANO TODAY, 2024, 卷号: 57, 页码: 15 作者:  Liang, Li;  Wang, Ning;  Li, Xiang;  Zhang, Zhuan;  Zhu, Zhu   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/08/22 Exosomes  Shape  Intracellular trafficking  ER-Targeted drug delivery  Anticancer therapy   Epigenetic Reprogramming Potentiates ICAM1 Antibody Drug Conjugates in Preclinical Models of Melanoma 期刊论文  OAI收割 ADVANCED SCIENCE, 2024, 卷号: 11 作者:  Zhang, Peng;  Tao, Changjuan;  Lu, Ye;  Li, Peijing;  Wang, Xing   |  收藏  |  浏览/下载：4/0  |  提交时间：2024/11/20 antibody drug conjugate  decitabine  ICAM1  melanoma  targeted therapy   Mitofilin in cardiovascular diseases: Insights into the pathogenesis and potential pharmacological interventions 期刊论文  OAI收割 PHARMACOLOGICAL RESEARCH, 2024, 卷号: 203, 页码: 20 作者:  Chaurembo, Abdallah Iddy;  Xing, Na;  Chanda, Francis;  Li, Yuan;  Zhang, Hui-juan   |  收藏  |  浏览/下载：23/0  |  提交时间：2024/06/27 Mitofilin  Cristae junction  Mitochondrial dysfunction  Cardiovascular diseases  Mitochondrial-targeted therapy   Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 12 作者:  Zou, Zhi-feng;  Yang, Lei;  Nie, Hui-jun;  Gao, Jing;  Lei, Shu-min   |  收藏  |  浏览/下载：16/0  |  提交时间：2024/05/22 proteolysis-targeting chimeras  tumor-targeted delivery  precise protein degradation  combination therapy  triple-negative breast cancer   SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10 作者:  Li, Wen-jing;  Xie, Cheng-ying;  Zhu, Xi;  Tang, Jiao;  Wang, Lei   |  收藏  |  浏览/下载：59/0  |  提交时间：2024/02/19 SIBP-03  HER3  HER3-targeted therapy  neuregulin 1  EGFR  HER2   The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors 期刊论文  OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32 作者:  Wei, Qing;  Li, Peijing;  Yang, Teng;  Zhu, Jiayu;  Sun, Lu   |  收藏  |  浏览/下载：57/0  |  提交时间：2024/02/27 Antibody-drug conjugate  Solid tumor  Combination therapy  Immunotherapy  Targeted therapy   Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12 作者:  Lin, Ting-ting;  Xiong, Wei;  Chen, Gui-hua;  He, Yang;  Long, Li   |  收藏  |  浏览/下载：17/0  |  提交时间：2024/01/26 osimertinib resistance  targeted drug delivery  liposomes  panobinostat  tumor-associated macrophage  combination therapy   Biocompatible Ferrofluid-Based Millirobot for Tumor Photothermal Therapy in Near-Infrared-II Window 期刊论文  OAI收割 ADVANCED HEALTHCARE MATERIALS, 2023, 页码: 12 作者:  Ji, Yiming;  Bai, Xue;  Sun, Hongyan;  Wang, Luyao;  Gan, Chunyuan   |  收藏  |  浏览/下载：16/0  |  提交时间：2024/02/22 ferrofluid robots  biocompatibility  targeted therapy   Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文  OAI收割 FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13 作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang   |  收藏  |  浏览/下载：34/0  |  提交时间：2022/12/22 HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies